Titre:
  • Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer
Auteur:Huober, J.; Holmes, Eileen; Baselga, José; Azambuja, Evandro; Untch, Michael; Fumagalli, Debora; Sarp, Severine; Lang, Istvan; Smith, Ian; Boyle, Frances; Xu, Binghe; Lecocq, Christophe; Wildiers, Hans; Jouannaud, Christelle; Hackman, John; Dasappa, Lokanatha; Ciruelos, Eva; Toral-Peña, Juan Carlos; Adamchuk, Hryhoriy; Hickish, Tamas; de la Peña, Lorena; Jackisch, Christian; Gelber, Richard; Piccart-Gebhart, Martine; Di Cosimo, Serena
Informations sur la publication:European journal of cancer, 118, page (169-177)
Statut de publication:Publié, 2019-09
Sujet CREF:Cancérologie
Mots-clés:Breast cancer
HER2 positive
Neoadjuvant
Note générale:SCOPUS: ar.j
DecretOANoAutActif
Langue:Anglais
Identificateurs:urn:issn:0959-8049
info:doi/10.1016/j.ejca.2019.04.038
info:pii/S0959804919302989
info:scp/85069972162
info:pmid/31377477